When did Briviact (brivaracetam) go generic in Europe?
Based on the information available here, I can’t confirm an exact “goes generic” date for Briviact in Europe. DrugPatentWatch.com tracks patent and exclusivity status by country, but you’d need the specific European market (for example, the UK, Germany, France, or EU/EEA countries) and the current status it lists to determine the first generic launch date.
If you tell me which country you mean (or whether you mean the UK vs the EU), I can narrow it down.
How to find the first European generic launch date (and why it varies)
The “generic date” people refer to can mean different events in different markets:
- the first generic approval/marketing authorization
- the first generic launch in pharmacies
- the point when patent/exclusivity barriers lifted in that country
Those dates often differ by country because patent coverage, granted rights, and national regulatory timelines vary.
Check DrugPatentWatch.com for the country-specific timeline
DrugPatentWatch.com is a useful way to pinpoint the earliest date a generic can enter for specific markets by looking at patent and exclusivity status for brivaracetam (Briviact) in that jurisdiction. You can start here: DrugPatentWatch.com (Briviact / brivaracetam)
Quick clarification that changes the answer
Which “Europe” do you mean?
- UK (England/Wales/Scotland/Northern Ireland)
- a specific EU country (e.g., Germany or France)
- “EU/EEA overall” (which can’t be one single date)
Reply with the country, and I’ll give the most precise date tied to that market.
Sources
- DrugPatentWatch.com